Hydrogen Is Promising for Medical Applications
Shin-ichi Hirano,
Yusuke Ichikawa,
Bunpei Sato,
Fumitake Satoh and
Yoshiyasu Takefuji
Additional contact information
Shin-ichi Hirano: Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan
Yusuke Ichikawa: Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan
Bunpei Sato: Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan
Fumitake Satoh: Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan
Yoshiyasu Takefuji: Faculty of Environment and Information Studies, Keio University, 5322 Endo, Fujisawa 252-0882, Japan
Clean Technol., 2020, vol. 2, issue 4, 1-13
Abstract:
Hydrogen (H 2 ) is promising as an energy source for the next generation. Medical applications using H 2 gas can be also considered as a clean and economical technology. Since the H 2 gas based on electrolysis of water production has potential to expand the medical applications, the technology has been developed in order to safely dilute it and to supply it to the living body by inhalation, respectively. H 2 is an inert molecule which can scavenge the highly active oxidants including hydroxyl radical (·OH) and peroxynitrite (ONOO − ), and which can convert them into water. H 2 is clean and causes no adverse effects in the body. The mechanism of H 2 is different from that of traditional drugs because it works on the root of many diseases. Since H 2 has extensive and various effects, it may be called a “wide spectrum molecule” on diseases. In this paper, we reviewed the current medical applications of H 2 including its initiation and development, and we also proposed its prospective medical applications. Due to its marked efficacy and no adverse effects, H 2 will be a next generation therapy candidate for medical applications.
Keywords: hydrogen; medical application; medical gas; oxidative stress; inflammation; clinical efficacy; clean technology (search for similar items in EconPapers)
JEL-codes: Q2 Q3 Q4 Q5 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.mdpi.com/2571-8797/2/4/33/pdf (application/pdf)
https://www.mdpi.com/2571-8797/2/4/33/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jcltec:v:2:y:2020:i:4:p:33-541:d:463055
Access Statistics for this article
Clean Technol. is currently edited by Ms. Shary Song
More articles in Clean Technol. from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().